問卷

TPIDB > Search Result

Search Result

篩選

List

1Cases

2025-03-01 - 2030-03-31

Phase III

Active
A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer
  • Condition/Disease

    Endometrial Cancer

  • Test Drug

    溶液用粉劑

Participate Sites
6Sites

Recruiting6Sites